ThePharmaLetter – Proteomics buys stake in CPR Pharma

Medtech pioneer Proteomics International has entered into a strategic alliance with fellow Australia-based CPR Pharma Services (CPR), targeting the high growth area of clinical trials and related research, with an offer to acquire 10% of CPR’s share capital through the issue of 4 million PIQ shares.

Article: Proteomics buys stake in CPR Pharma

  • This field is for validation purposes and should be left unchanged.